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Abstract 27 
Introduction: Clinicians typically use findings from cohort studies to objectively inform 28 
judgements regarding the potential (dis)advantages of prescribing a new prosthetic device. 29 
However, before finalising prescription a clinician will typically ask a patient to ‘try out’ a 30 
change of prosthetic device while the patient is at the clinic. Observed differences in gait 31 
when using the new device should be the result of the device’s mechanical function, but 32 
could also conceivably be due to patient related factors which can change from day-to-day 33 
and can thus make device comparisons unreliable. To determine whether a device’s 34 
mechanical function consistently has a more meaningful impact on gait than patient-related 35 
factors, the present study undertook quantitative gait analyses of a trans-tibial amputee 36 
walking using two different foot-ankle devices on two occasions over a year apart. If the 37 
observed differences present between devices, established using quantitative gait analysis, 38 
were in the same direction and of similar magnitude on each of the two occasions, this would 39 
indicate that device-related factors were more important than patient-related factors. 40 
Methods: One adult male with a unilateral trans-tibial amputation completed repeated 41 
walking trials using two different prosthetic foot devices on two separate occasions, 14 42 
months apart. Walking speed and sagittal plane joint kinematics and kinetics for both limbs 43 
were assessed on each occasion. Clinically meaningful differences in these biomechanical 44 
outcome variables were defined as those with an effect size difference (d) between prosthetic 45 
conditions of at least 0.4 (i.e. ‘medium’ effect size).  46 
Results: Eight variables namely, walking speed, prosthetic ‘ankle’ peak plantar- and dorsi-47 
flexion and peak positive power, and residual knee loading response flexion, peak stance-48 
phase extension and flexion moments and peak negative power, displayed clinically 49 
meaningful differences (d > 0.4) between foot devices during the first session. All eight of 50 
these showed similar effect size differences during the second session despite the participant 51 
being heavier and older. 52 
Conclusions: Findings suggest that a prosthetic device’s mechanical function consistently has 53 
a more meaningful impact on gait than patient-related factors. These findings support the 54 
current clinical practice of making decisions regarding prosthetic prescription for an 55 
individual, based on a single session evaluation of their gait using two different devices. 56 
However, to confirm this conclusion, a case series using the same approach as the present 57 
study could be undertaken. 58 
 59 
Keywords: Gait analysis, Lower-limb amputation, Methodology, Prosthetics, Foot device 60 
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Introduction  61 
Within a research setting, the efficacy of a particular prosthetic device is typically 62 
determined by comparing group mean biomechanical outcome variables (e.g. peak residual 63 
knee flexion during stance) from a cohort of lower-limb amputees performing locomotor 64 
tasks when using one device versus using a different device, typically with  differing design 65 
features
1-8
. Findings from such research is used by clinicians to objectively inform 66 
judgements regarding the potential (dis)advantages of prescribing one prosthetic device 67 
compared to another. Interpreting the findings from research in this way is based upon the 68 
assumption that the differences in biomechanical outcome variables between prosthetic 69 
conditions are solely a result of the prosthetic components and that the observed effect would 70 
be present for any patient with a similar level of amputation, activity level and health status 71 
as those reported in the research. However, this assumption may not necessarily be valid and 72 
even if it is, the applicability of such research findings to a clinical setting, where decisions 73 
regarding prosthetic prescription are made on a patient by patient basis, is questionable. For 74 
example, in a cohort study comparing the efficacy of one prosthetic device versus another, it 75 
is entirely possible that group mean biomechanical outcome variables may indicate a 76 
statistically significant effect in one direction, even though some members of the group 77 
display minimal changes, or even changes in the opposing direction. Based on the findings 78 
from such studies, a clinician could make an evidence-based decision regarding prosthetic 79 
prescription that may have a negative outcome for a patient. Accordingly, before finalising 80 
prosthesis prescription, clinicians will typically ask a patient to ‘try out’ any recommended 81 
change in prosthetic device while the patient is at their clinic, with the necessary adjustments 82 
to alignment and the like being made with a view to optimising the device’s function during 83 
gait. Any differences in gait observed at the clinic when the patient switches to using the new 84 
device are expected to, and may indeed, be a result of the function of the new prosthetic 85 
device. However, it is possible that evaluation of a patient’s gait made on any day can also be 86 
affected by patient-related factors (e.g. weight, physical condition, motivation) rather than 87 
soley device-related factors alone. 88 
Therefore, in order to investigate the efficacy of carrying out such single-session 89 
evaluations, the current study undertook quantitative gait analyses of an individual with a 90 
trans-tibial amputation when using two different foot-ankle devices, on two separate 91 
occasions 14 months apart. It was reasoned that if quantitative gait analysis showed that the 92 
differences observed when using one device compared to the other were in the same direction 93 
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and of similar magnitude on each of the two occasions, this would indicate that device-related 94 
factors were more important than patient-related factors. This would highlight that a single-95 
session qualitative comparison of an amputee’s gait using two different foot-ankle devices, as 96 
typically occurs in a clinic, is a valid approach in finalising descisions regarding prosthetic 97 
prescription, and, furthermore, that prosthetic prescription decisions should not be made 98 
solely using evidence from research evaluating group mean response to using a new device. 99 
 100 
Methods 101 
One healthy adult male (age 35.8 years, mass 90.4 kg, height 1.86 m at the time of the 102 
first data collection session) with a unilateral trans-tibial amputation, and described as being 103 
K4 on the Medicare Scale by his prescribing clinician, participated. Amputation of the right 104 
limb had been conducted, as a result of trauma, 9.2 years prior to the first data collection 105 
session. The habitual prosthetic foot device (at the time of both data collection sessions) was 106 
an Echelon VT (Chas. A Blatchford and Sons Ltd., Basingstoke, UK). The participant had 107 
used a full-contact, suction socket with silicon liner for 12 months prior to the first data 108 
collection session, and was using the same at the time of the second data collection session. 109 
Data were recorded while the participant completed repeated walking trials using two 110 
different types of prosthetic feet. A second, identical data collection session was conducted 111 
14 months later (at which time the participant’s mass had increased by 6.0 kg). The study 112 
gained ethical approval from the University of Bradford’s bioethics committee, with written 113 
informed consent being obtained from the participant prior to participation.  114 
In the present study, the protocol, trial order, laboratory set up, experimenters and 115 
prosthetist were identical for both data collection sessions. Segmental kinematic and ground 116 
reaction force data were recorded at 200 Hz using a ten camera motion capture system (Vicon 117 
MX, Oxford, UK) and two floor mounted force platforms (AMTI, Watertown, MA, USA) 118 
while the participant completed overground walking trials along a flat and level 8 m walkway 119 
(full details of the marker configuration used to determine segmental kinematics are reported 120 
in De Asha et al., 
9
). The participant completed 12 walking trials at a self-selected walking 121 
speed, using each of two prosthetic foot devices (details below) with stance phase kinetic data 122 
being recorded for the intact and prosthetic limbs (six trials for each limb in each prosthetic 123 
condition; 24 trials in total). 124 
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 To avoid habituation affecting the comparisons made between prosthetic feet, during 125 
both data collection sessions the participant used foot devices (an Elan and Epirus; both Chas. 126 
A Blatchford and Sons Ltd., Basingstoke, UK) which were different from his currently 127 
prescribed foot. Both the Elan and Epirus feet incorporate a dynamic-response foot base with 128 
the same shape and design of heel and fore-foot keels and both have an ankle device that 129 
passively articulates during stance. In both feet, deflection of the heel and forefoot keels 130 
provides simulated 'ankle' motion, with actual articulation occurring at the ankle device, 131 
which in the Elan is governed by a microprocessor controlled hydraulic unit, while in the 132 
Epirus it is governed by the elastic resistance offered by a rubber ball-joint. The overall 133 
prosthesis length, socket and suspension were unchanged between devices. However, as it 134 
was impossible to replicate exactly the foot alignment of the first data collection during the 135 
second, it was decided to use the same approach to obtain ‘optimal’ alignment for each foot 136 
at each session. Thus, as is common practice clinically, foot alignment was decided upon by a 137 
mixture of feedback regarding perceived function and comfort from the participant and the 138 
expertise of the prosthetist. After each foot device had been fitted the participant walked on it 139 
for a period of approximately 20 minutes prior to data collection to enable the participant to 140 
become accustomed to it. 141 
Initial processing of marker trajectories were undertaken within Nexus software 142 
(Vicon, Oxford, UK). Marker trajectory and ground reaction force data were then exported in 143 
C3D format to Visual 3D software (C-Motion, Germantown, MD, USA), where it was then 144 
filtered using a fourth-order, zero-lag Butterworth filter with a 6 Hz cut-off, and all further 145 
processing was completed (for more details regarding data processing see De Asha et al. 
9
). 146 
Walking speed and sagittal plane joint kinematics and kinetics for both limbs have been 147 
shown by previous research to be important outcome variables in unilateral amputee gait
10
. 148 
Therefore we assessed; average walking speed, positive and negative peaks in sagittal plane 149 
joint moments and powers, peak flexion and extension at hips, knees and ankles (dorsi- and 150 
plantar-flexion) and the joint angle at specific gait events (e.g. initial contact, peak loading 151 
response, toe-off). Clinically meaningful differences in these biomechanical outcome 152 
variables were defined as those with an effect size difference (d) between prosthetic 153 
conditions of at least 0.4 (‘medium’ effect size)11. No inferential statistical tests were applied.  154 
 155 
 156 
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Results 157 
In total, there were eight biomechanical variables where clinically meaningful 158 
differences (d > 0.4) were evident between foot types during the first data collection session. 159 
These variables were walking speed, peak plantar- and dorsi-flexion at the prosthetic ‘ankle’, 160 
residual knee loading response flexion, peak positive power during early stance at the 161 
prosthetic ‘ankle’, peak negative residual knee power during late stance, and peak stance-162 
phase extension and flexion moments at the residual knee (direction and magnitude of 163 
differences are shown at Table 1 and Figures 1 and 2). The mean (SD) effect size difference 164 
between foot types was 0.99 (0.48). During the second data collection session, differences 165 
between foot types in the same eight variables were in the same direction and had much the 166 
same effect size, mean 0.89 (0.51), as those determined during the first session (Table 1).  167 
INSERT TABLE 1 168 
INSERT FIGURE 1  169 
INSERT FIGURE 2 170 
Discussion 171 
The aim of the current study was to investigate the efficacy of making decisions 172 
regarding prosthetic foot prescription for an individual patient, based on a single session 173 
comparison of their gait using two different foot-ankle devices. To fulfil this aim we 174 
undertook quantitative gait analyses of a an individual with a trans-tibial amputation, using 175 
two different foot-ankle devices, on two separate occasions 14 months apart. 176 
The results indicated that eight biomechanical variables had ‘medium’ or ‘large’ 177 
effect size differences between prosthetic foot types (d > 0.4) during the first data collection 178 
session. All eight of these variables had the same directional and comparable effect size 179 
differences between prosthetic conditions during the second data collection session, which 180 
was conducted 14 months after the initial session with the participant now older and heavier 181 
by 6kg, indicating an increase in body mass index from 26.1 to 27.9 (implying his physical 182 
conditioning had altered). The average effect size difference between prosthetic foot types 183 
was slightly greater in the first session than the second (session 1, d = 0.99; session 2, d = 184 
0.89), although average effect sizes were similarly ‘large’ for both data collection sessions. 185 
Therefore, these results suggest that a single session comparison of the gait of an individual 186 
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with unilateral trans-tibial amputation using two different foot-ankle devices, as is typically 187 
undertaken in a clinical setting (albeit in a qualitative manner), is appropriate for identifying 188 
biomechanical differences between prosthetic devices. Hence it is a valid type of evaluation 189 
to conduct when finalising decisions about prosthetic prescription.  190 
Despite an increase in participant mass of 6kg between sessions, both feet had the 191 
same category of heel and forefoot keel stiffness on both occasions. With such an increase in 192 
body mass, absolute joint kinetic values would have increased between testing sessions, so in 193 
order to ensure comparisons were valid all joint kinetic parameters were normalised to body 194 
mass. These normalised values, which had comparable magnitudes between sessions, showed 195 
meaningful effect size differences between prosthetic foot types in both data collection 196 
sessions; suggesting the change in foot type was the main cause of such differences, not 197 
patient-related factors. These findings support our stated supposition. 198 
Self-selected walking speed was higher during both sessions (‘medium’ effect sizes) 199 
when the participant used the Elan, compared to the Epirus foot device. Increased self-200 
selected walking speed can be considered a global descriptor of improved gait function.
12
 201 
Thus speed increases when using a particular foot device provide an indication that any 202 
accompanying changes in other parameters when using the new device may also be 203 
beneficial. Thus in the present study, the reduction in peak negative residual knee power 204 
during late stance when using the Elan compared to the Epirus foot device, for example, can 205 
be interpreted as a beneficial change. 206 
Generally, the magnitudes of effect size differences between prosthetic conditions 207 
appear to reflect relatively low inter-trial variability rather than large changes to average 208 
values (see Figures 1 and 2). This is likely due to the participant, who was assessed as being 209 
K4 on the Medicare scale, having excellent gait function. Whilst data  from such a participant 210 
may be limited in terms of its generalisibility to the wider population group, such a 211 
participant would be better able to adjust to using different, non-habitual feet than a 212 
participant with a lower level of function. It is quite possible that the differences between 213 
prosthetic conditions observed in the present study may well be amplified in an individual 214 
with a lower Medicare classification due to them being more affected by the function and/or 215 
design features of a particular prosthetic device, compared to an individual with higher levels 216 
of function.  217 
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In conclusion, the findings of this study indicate that the direction and effect sizes of 218 
differences in biomechanical outcomes when using one prosthetic foot versus another 219 
remained more or less constant when such assessment was conducted 14 months later, even 220 
though certain participant specific parameters (e.g. body mass, age) were different between 221 
sessions. These findings support our stated (a priori) supposition and lends support to the 222 
current clinical practice of finalising decisions regarding prosthetic prescription for an 223 
individual, based on a single session comparison of their gait using two different devices 224 
(typically, new device compared to habitual device). Potentially, future studies could 225 
undertake a case-series using the same approach as the present study to support, or refute, the 226 
findings of this study.  227 
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 279 
Table 1. A list of mean (SD) variables with clinically meaningful inter-foot differences.  280 
 Data collection session 1 Data collection session 2 
Elan Epirus d Elan Epirus d 
Walking speed 
(m/s) 
1.39 
(0.08) 
1.31 
(0.10) 
0.65 
1.38 
(0.09) 
1.33 
(0.07) 
0.46 
Joint kinematics 
Prosthetic ‘ankle’ peak 
‘plantarflexion’ 
(°) 
7.3 
(1.6) 
9.4 
(1.5) 
0.93 
7.6 
(1.9) 
9.8 
(1.5) 
0.96 
Prosthetic ‘ankle’ peak 
‘dorsiflexion’ 
(°) 
11.3 
(1.8) 
12.5 
(1.6) 
0.51 
11.8 
(1.1) 
13.0 
(1.5) 
0.66 
Residual knee loading 
response flexion 
 (°) 
22.4 
(3.4) 
19.9 
(1.2) 
0.72 
22.5 
(2.0) 
20.4 
(1.6) 
0.78 
Joint kinetics 
Prosthetic ’ankle’ peak 
rotation positive power 
early stance (W/kg) 
0.17 
(0.24) 
0.47 
(0.13) 
1.13 
0.19 
(0.14) 
0.42 
(0.12) 
1.21 
Residual knee peak 
rotation negative power 
late stance  
(W/kg) 
1.51 
(0.30) 
1.76 
(0.25) 
0.62 
1.89 
(0.37) 
2.15 
(0.17) 
0.65 
Residual knee peak 
extension moment  
(Nm/kg) 
0.56 
(0.08) 
0.40 
(0.04) 
1.84 
0.59 
(0.12) 
0.53 
(0.07) 
0.43 
Residual knee peak 
flexion moment  
(Nm/kg) 
0.20 
(0.12) 
0.43 
(0.09) 
1.57 
0.21 
(0.05) 
0.33 
(0.03) 
1.98 
 281 
 282 
 283 
 284 
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 285 
Figure 1 Mean (SD) sagittal plane angular displacement at the prosthetic ‘ankle’ (top) and 286 
residual knee (bottom) using Elan (dashed lines) and Epirus (solid lines) foot devices. Data 287 
collection session one is on the left and session two on the right. 288 
  289 
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 290 
Figure 2 Mean (SD) sagittal plane prosthetic ‘ankle’ joint rotation power (top; power 291 
generation is positive, absorbtion is negative) and residual knee joint moment (bottom; 292 
internal extension moment is positive, flexion moment is negative) using Elan (dashed lines) 293 
and Epirus (solid lines) foot devices. Data collection session one is on the left and session 294 
two on the right. 295 
